Stay updated with breaking news from Talphera Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Talphera, Inc. (NASDAQ:TLPH – Get Free Report) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 121,200 shares, a decline of 17.7% from the April 30th total of 147,300 shares. Based on an average daily volume of 76,100 shares, the short-interest ratio is […]
SAN MATEO, Calif., May 20, 2024 /PRNewswire/ -- Talphera, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically...
HC Wainwright reiterated their buy rating on shares of Talphera (NASDAQ:TLPH – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the stock. HC Wainwright also issued estimates for Talphera’s Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings at ($0.21) EPS, FY2024 […]
HC Wainwright restated their buy rating on shares of Talphera (NASDAQ:TLPH – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The firm currently has a $6.00 target price on the stock. Separately, Maxim Group started coverage on Talphera in a report on Monday, May 6th. They issued a buy rating […]
HC Wainwright reissued their buy rating on shares of Talphera (NASDAQ:TLPH – Free Report) in a research note published on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 target price on the stock. Separately, Maxim Group started coverage on Talphera in a research report on Monday, May 6th. They issued a buy rating and […]